当地时间1月13日,因美纳公司宣布推出“十亿细胞图谱”,为因美纳新业务部门BioInsight推出的首个数据产品。该图谱是其在三年内构建“五十亿细胞图谱”计划的首批成果,将以一年内20 PB的速率产出单细胞转录组数据。在与阿斯利康、美国默克公司和礼来公司等作为发起参与方组成的联盟框架下,该图谱已开始针对一组经甄选的细胞系开展构建工作,以推动药物靶点验证、大规模训练先进AI模型,并推进此前难以触及的...
Source Link当地时间1月13日,因美纳公司宣布推出“十亿细胞图谱”,为因美纳新业务部门BioInsight推出的首个数据产品。该图谱是其在三年内构建“五十亿细胞图谱”计划的首批成果,将以一年内20 PB的速率产出单细胞转录组数据。在与阿斯利康、美国默克公司和礼来公司等作为发起参与方组成的联盟框架下,该图谱已开始针对一组经甄选的细胞系开展构建工作,以推动药物靶点验证、大规模训练先进AI模型,并推进此前难以触及的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.